Janssen's COVID-19 vaccine under EU review over blood clots

Europe's medicines watchdog said it was reviewing reports of rare blood clots in four people who received the Covid-19 vaccine developed by Janssen, the pharmaceutical arm of Johnson & Johnson. In a statement, the European Medicines Agency (EMA) said its safety committee had started a review to assess reports of thromboembolic events, which occurred through the formation of blood clots and resulted in the obstruction of a vessel in people who received the Janssen jab, Xinhua news agency reported on Friday.

from IndiaTV World: Google News Feed https://ift.tt/2OCjv5d